| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 |
| filingDate |
2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab1b091a5f6b1ea6c2ce530ce9644642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2c58c0a1227cc8b33ae139d0223c14b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d3183d4bb6f11844fba6230e4a3bc5 |
| publicationDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180043184-A |
| titleOfInvention |
composition comprising syringaresinol for preventing or treating neurological and mental disorders |
| abstract |
The present invention relates to a composition for the prevention or treatment of neurological diseases and psychiatric disorders including Cirigaresinol. The cyclin regenol according to the present invention has an effect of reducing excitatory synapse conduction in the central region and reducing the activity of epilepsy and animals. These excitatory synaptic conduction inhibitory effects can be effectively used for the prevention and treatment of all neurological diseases and psychiatric disorders accompanied by synaptic dysfunction and excitatory-inhibitory synapse conduction imbalance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021060922-A1 |
| priorityDate |
2016-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |